国际妇科内镜学会(ISGE)关于SARS-CoV-2大流行演变阶段妇科内镜的指南与推荐
国际妇科内镜学会(ISGE)针对SARS-CoV-2大流行演变阶段发布妇科内镜指南与推荐。指南指出决策因素随大流行阶段、防控政策、专业技术和基础设施而变化,责任是确保所有医护人员、辅助人员与患者安全。择期手术尽可能术前40小时普遍检测SARS-CoV-2,确诊阳性者推迟手术,优先处理恶性肿瘤等相对紧急病例,支持良性非危及生命手术的医学优化与推迟;推荐尽可能腹腔镜并允许早期出院,任何有肠道受累风险的操作应行开腹手术。紧急手术方面,各单位应基于能力制定风险评估流程图,筛查症状,有症状者必须检测;确诊阳性者尽量优化内科管理并推迟至康复,仅行急诊或危及生命手术;推荐避免插管和通气,尽可能使用局部或区域麻醉。
要点
- 择期手术尽可能在术前40小时普遍检测SARS-CoV-2,确诊阳性者推迟手术。
- 优先处理恶性肿瘤等相对紧急病例,ISGE支持良性非危及生命手术的医学优化与推迟。
- 尽可能腹腔镜并允许早期出院;任何有肠道受累风险的操作应行开腹手术(粪便中病毒RNA载量高)。
- 确诊阳性者避免插管和通气,尽可能使用局部或区域麻醉;筛查或检测阴性者可全身麻醉和腹腔镜,同时严格执行感染控制方案。
- 筛查阳性及确诊阳性且不能安全推迟的手术,须全套个人防护装备,仅暴露必要人员,有条件使用负压手术室。
适用人群与场景
- 所有执业的妇科内镜医师及接受妇科内镜手术的患者。
- 决策因素随大流行阶段、防控政策、专业技术和现有基础设施而变化。
- 择期手术:相对紧急病例如恶性肿瘤优先;良性非危及生命手术支持医学优化与推迟。
- 紧急手术:基于各单位能力进行风险评估。
诊断标准与关键阈值
- 择期手术:尽可能术前40小时普遍检测SARS-CoV-2。
- 紧急手术:筛查症状,有症状患者必须检测。
- 筛查低风险或检测阴性者,尽管不能排除携带者和假阴性,应强烈考虑腹腔镜。
处置流程与药物剂量
- 择期手术尽可能术前40小时普遍检测SARS-CoV-2,确诊阳性者推迟手术。
- 优先处理恶性肿瘤等相对紧急病例,ISGE支持良性非危及生命手术的医学优化与推迟。
- 尽可能腹腔镜并允许早期出院;任何有肠道受累风险的操作应行开腹手术(研究显示粪便中病毒RNA载量高)。
- 紧急手术:各单位基于能力制定风险评估流程图,筛查症状,有症状者必须检测。
- 确诊SARS-CoV-2阳性者,尽量优化内科管理并推迟至康复,仅行急诊或危及生命手术。
- SARS-CoV-2阳性患者避免插管和通气,尽可能使用局部或区域麻醉;筛查或检测阴性者可全身麻醉和腹腔镜,同时严格执行感染控制方案。
- 筛查阳性及确诊阳性且不能安全推迟的手术,须全套个人防护装备,仅暴露必要人员,有条件使用负压手术室。
- 开腹和阴道操作中可使用吸引以减少飞沫和生物气溶胶传播。
红旗征与不能漏的情况
- 确诊SARS-CoV-2阳性者,除急诊或危及生命手术外应推迟手术。
- 有肠道受累风险的操作应行开腹手术,因粪便中病毒RNA载量高。
- SARS-CoV-2阳性患者避免插管和通气,以降低气溶胶传播风险。
研究设计与关键结果
- ISGE综述当前与COVID-19危机期间妇科及内镜手术相关文献后提出上述指南与推荐。
- ISGE大体支持当前国际趋势,即基于个案风险评估优先选择腹腔镜而非开腹,同时认识到各国在微创操作技术水平和可及性上的差异。
证据类型、等级与局限
- 证据类型:指南(国际学会指南与推荐)。
- 局限:原文未报告局限性
对床旁实践的改变
- 择期妇科内镜手术前应尽可能在术前40小时普遍检测SARS-CoV-2,阳性者推迟手术。
- 良性非危及生命手术可进行医学优化并推迟,恶性肿瘤等相对紧急病例优先处理。
- 尽可能选择腹腔镜并允许早期出院;有肠道受累风险的操作选择开腹。
- SARS-CoV-2阳性患者避免插管和通气,尽可能使用局部或区域麻醉。
- 微创手术中采取减少生物气溶胶产生与烟雾泄漏的策略,并确保烟雾安全排出。
- 大流行高峰后对工作人员进行汇报和心理健康筛查,按需提供心理支持。
指南或共识出处
- 国际妇科内镜学会(ISGE)指南与推荐,发表于European Journal of Obstetrics & Gynecology and Reproductive Biology。
提炼说明
- 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has raised some important interrogations on minimally invasive gynaecological surgery. The International Society for Gynecologic Endoscopy (ISGE) has taken upon itself the task of providing guidance and best practice policies for all practicing gynaecological endoscopists. Factors affecting decision making processes in minimal invasive surgery (MIS) vary depending on factors such as the phase of the pandemic, policies on control and prevention, expertise and existing infrastructure. Our responsibility remains ensuring the safety of all health care providers, ancillary staff and patients during this unusual period. We reviewed the current literature related to gynecological and endoscopic surgery during the Coronavirus Disease 19 (COVID-19) crisis. Regarding elective surgery, universal testing for SARS-CoV-2 infection should be carried out wherever possible 40 h prior to surgery. In case of confirmed positive case of SARS-CoV-2, surgery should be delayed. Priority should be given to relatively urgent cases such as malignancies. ISGE supports medical optimization and delaying surgery for benign non-life-threatening surgeries. When possible, we recommend to perform cases by laparoscopy and to allow early discharges. Any procedure with risk of bowel involvement should be performed by open surgery as studies have found a high amount of viral RNA (ribonucleic acid) in stool. Regarding urgent surgery, each unit should create a risk assessment flow chart based on capacity. Patients should be screened for symptoms and symptomatic patients must be tested. In the event that a confirmed case of SARS-CoV-2 is found, every attempt should be made to optimize medical management and defer surgery until the patient has recovered and only emergency or life-threatening surgery should be performed in these cases. We recommend to avoid intubation and ventilation in SARS-CoV-2 positive patients and if at all possible local or regional anesthesia should be utilized. Patients who screen or test negative may have general anesthesia and laparoscopic surgery while strict protocols of infection control are upheld. Surgery in screen-positive as well as SARS-CoV-2 positive patients that cannot be safely postponed should be undertaken with full PPE with ensuring that only essential personnel are exposed. If available, negative pressure theatres should be used for patients who are positive or screen high risk. During open and vaginal procedures, suction can be used to minimize droplet and bioaerosol spread. In a patient who screens low risk or tests negative, although carrier and false negatives cannot be excluded, laparoscopy should be strongly considered. We recommend, during minimal access surgeries, to use strategies to reduce production of bioaerosols (such as minimal use of energy, experienced surgeon), to reduce leakage of smoke aerosols (for example, minimizing the number of ports used and size of incisions, as well as reducing the operating pressures) and to promote safe elimination of smoke during surgery and during the ports' closure (such as using gas filters and smoke evacuation systems). During the post-peak period of pandemic, debriefing and mental health screening for staff is recommended. Psychological support should be provided as needed. In conclusion, based on the existent evidence, ISGE largely supports the current international trends favoring laparoscopy over laparotomy on a case by case risk evaluation basis, recognizing the different levels of skill and access to minimally invasive procedures across various countries.
参考来源
- Thomas V, Maillard C, Barnard A, et al. International Society for Gynecologic Endoscopy (ISGE) guidelines and recommendations on gynecological endoscopy during the evolutionary phases of the SARS-CoV-2 pandemic. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 32866856. doi:10.1016/j.ejogrb.2020.08.039
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。